Immune checkpoint Inhibitor–Induced diarrhea and Colitis: Incidence and Management. A systematic review and Meta-analysis
Open Access
- 26 July 2022
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 109, 102440
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Development and validation of the Nancy histological index for UCGut, 2015
- Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer CenterJournal of Clinical Oncology, 2015
- Vascular endothelial growth factor receptor tyrosine kinase inhibitors versus bevacizumab in metastatic colorectal cancer: A systematic review and meta-analysisMolecular and Clinical Oncology, 2015
- Interleukin 6 and Rheumatoid ArthritisBioMed Research International, 2014
- Tumor Necrosis Factor Inhibitors for Inflammatory Bowel DiseaseNew England Journal of Medicine, 2013
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2013
- α-CTLA-4 mAb-associated PanenteritisAmerican Journal of Surgical Pathology, 2008
- Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4Journal of Clinical Oncology, 2006
- A simple clinical colitis activity indexGut, 1998
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987